- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Wockhardt's board meeting held today approved the consolidated financial results for the quarter ended June 30, 2025. The company reported revenue from operations of Rs. 738 crore. It posted a consolidated loss after tax of Rs. 108 crore, primarily due to an exceptional charge of Rs. 97 crore. This charge stems from the decision to exit the US generic pharmaceutical segment, resulting in goodwill impairment related to its US step-down subsidiaries. This strategic move aims to streamline operations.